Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex Tablet 80 mg.
Phase of Trial: Phase IV
Latest Information Update: 22 Jan 2013
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Acronyms CAMON
- Sponsors AstraZeneca
- 10 Jun 2017 Biomarkers information updated
- 01 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Dec 2010 Planned end date changed from 1 Apr 2012 to 1 Mar 2012 as reported by ClinicalTrials.gov.